02/10
Headlines

RNN

Whats Hot Today: Bank of America Corporation (NYSE:BAC), General Motors Company (NYSE:GM), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Skilled Healthcare Group (NYSE:SKH), Metabolix (NASDAQ:MBLX)

Jayne Crisman02 mins

Bank of America Corporation (NYSE:BAC), will avoid easing mortgage standards even as regulators seek to expand lending, Chief Executive Officer Brian T. Moynihan said. Bank of America Corporation (NYSE:BAC) belongs to Financial sector. Its net profit margin is 8.80% and weekly performance is -0.29%. On last trading day company shares ended up $17.29. Bank of…

Read More

Top Wall Street Stories: China Sunergy (NASDAQ:CSUN), Twitter (NYSE:TWTR), Rexahn Pharmaceuticals (NYSEMKT:RNN), STR (NYSE:STRI), Hersha Hospitality (NYSE:HT)

John Meady03 mins

China Sunergy Co. Ltd. (NASDAQ:CSUN) belongs to Technology sector. Its net profit margin is -13.40% and weekly performance is -6.88%. On last trading day company shares ended up $2.98. China Sunergy Co. Ltd. (NASDAQ:CSUN) distance from 50-day simple moving average (SMA50) is -3.05%. Twitter Inc. (TWTR) announced today that it is expanding its Twitter Ads…

Read More

Shining on Major News: Rexahn Pharmaceuticals (NYSEMKT:RNN), Anadigics (NASDAQ:ANAD), Markit (NASDAQ:MRKT), Educational Development Corporation (NASDAQ:EDUC), Chindex International Inc. (NASDAQ:CHDX)

Colin Pettis02 mins

Rexahn Pharmaceuticals, Inc. (nyse mkt:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and financial results for the quarter ended June 30, 2014. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) belongs to Healthcare sector. Its weekly performance is 2.86%. On last trading day…

Read More

Healthcare ACtive Stocks: Rexahn Pharmaceuticals (NYSEMKT:RNN), Eli Lilly (NYSE:LLY), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Gentiva Health Services (NASDAQ:GTIV)

Colin Pettis04 mins

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) said, “We continue to enroll patients in each of our three clinical trials as expected, and as planned for. By the end of 2014, we expect to achieve key milestones in each trial. In Q4 we expect to have data from our Phase I trial of Supinoxin in cancer patients with…

Read More

Healthcare Most Active Movers: Bristol-Myers Squibb (NYSE:BMY), Ariad Pharmaceuticals (NASDAQ:ARIA), Avanir Pharmaceuticals (NASDAQ:AVNR), Rexahn Pharmaceuticals (NYSEMKT:RNN)

Kevin Long03 mins

Zacks restated their neutral rating on shares of Bristol-Myers Squibb Co (NYSE:BMY) in a research note issued to investors on Wednesday. The firm currently has a $52.00 price target on the stock. Bristol-Myers Squibb Co (NYSE:BMY) stock performance was -1.14% in last session and finished the day at $49.52. Traded volume was 8.89million shares in…

Read More
Gilead Sciences GILD NASDAQ:GILD

Biotech Losers: MannKind Corporation (NASDAQ:MNKD), Rexahn Pharmaceuticals (NYSEMKT:RNN), ZIOPHARM Oncology (NASDAQ:ZIOP), Seattle Genetics (NASDAQ:SGEN)

Kristen Barton02 mins

MannKind Corporation (NASDAQ:MNKD) announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for AFREZZA(R) by three months to July 15, 2014 in order to provide time for a full review of information submitted by MannKind in response to the FDA’s requests.MannKind Corporation (NASDAQ:MNKD) stock performance…

Read More